ID

34974

Description

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02063724

Lien

https://clinicaltrials.gov/show/NCT02063724

Mots-clés

Versions (1)
  1. 06/02/2019 06/02/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

6 février 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT02063724

Anglais

Eligibility Breast Cancer NCT02063724

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
women over age 18 years.
Description

Gender | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
subjects with invasive breast cancer at least stage iiia greater than or equal to n2 (4 positive nodes) or have recurrent metastatic breast cancer rendered ned by any means that are classic her-2 3+ 30%, 2+ ihc and fish positive or her-2 2+ fish negative verified by the department of pathology at the hospital of the university of pennsylvania that have completed chemotherapy and/or trastuzumab and are within 1 year from there last treatment and have no evidence of disease.
Description

Invasive carcinoma of breast TNM Breast tumor staging | BREAST CANCER METASTATIC RECURRENT | HER2 Status Immunohistochemistry | HER2 Status FISH | Chemotherapy Completed | trastuzumab

Type de données

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0474926
UMLS CUI [2]
C0741681
UMLS CUI [3,1]
C1512413
UMLS CUI [3,2]
C0021044
UMLS CUI [4,1]
C1512413
UMLS CUI [4,2]
C0162789
UMLS CUI [5,1]
C0392920
UMLS CUI [5,2]
C0205197
UMLS CUI [6]
C0728747
patients deemed to require anti-estrogen therapy for treatment of their breast cancer can continue anti-estrogen therapy during vaccinations
Description

Antioestrogen therapy Breast Carcinoma | Vaccination

Type de données

boolean

Alias
UMLS CUI [1,1]
C0854638
UMLS CUI [1,2]
C0678222
UMLS CUI [2]
C0042196
women of childbearing age with a negative pregnancy test documented prior to enrollment.
Description

Childbearing Potential Pregnancy test negative

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
subjects with ecog performance status score of 0 or 1 (appendix d).
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
subjects willing to use birth control if necessary
Description

Contraceptive methods Willing

Type de données

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
subjects who have voluntarily signed a written informed consent in accordance with institutional policies after its contents have been fully explained to them.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating females.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
subjects with positive hiv or hepatitis c at baseline by report.
Description

HIV Seropositivity | Hepatitis C positive

Type de données

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C1112419
subjects with coagulopathies, including thrombocytopenia with platelet count less than 75,000, inr greater than 1.5 and partial thromboplastin time greater than 50 sec
Description

Blood Coagulation Disorders | Thrombocytopenia | Platelet Count measurement | International Normalized Ratio | Partial thromboplastin time finding

Type de données

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0040034
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0525032
UMLS CUI [5]
C1531697
subjects with major cardiac illness muga less than 50% ef.
Description

Heart Disease Major | Cardiac ejection fraction MUGA

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205164
UMLS CUI [2,1]
C0232174
UMLS CUI [2,2]
C0521317
subjects with pre-existing medical illnesses or medications which might interfere with the study as determined by pi.
Description

Pre-existing condition Interferes with Clinical Trial | Pharmaceutical Preparations Interfere with Clinical Trial

Type de données

boolean

Alias
UMLS CUI [1,1]
C0521987
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0008976
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT02063724

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
women over age 18 years.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Invasive carcinoma of breast TNM Breast tumor staging | BREAST CANCER METASTATIC RECURRENT | HER2 Status Immunohistochemistry | HER2 Status FISH | Chemotherapy Completed | trastuzumab
Item
subjects with invasive breast cancer at least stage iiia greater than or equal to n2 (4 positive nodes) or have recurrent metastatic breast cancer rendered ned by any means that are classic her-2 3+ 30%, 2+ ihc and fish positive or her-2 2+ fish negative verified by the department of pathology at the hospital of the university of pennsylvania that have completed chemotherapy and/or trastuzumab and are within 1 year from there last treatment and have no evidence of disease.
boolean
C0853879 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0741681 (UMLS CUI [2])
C1512413 (UMLS CUI [3,1])
C0021044 (UMLS CUI [3,2])
C1512413 (UMLS CUI [4,1])
C0162789 (UMLS CUI [4,2])
C0392920 (UMLS CUI [5,1])
C0205197 (UMLS CUI [5,2])
C0728747 (UMLS CUI [6])
Antioestrogen therapy Breast Carcinoma | Vaccination
Item
patients deemed to require anti-estrogen therapy for treatment of their breast cancer can continue anti-estrogen therapy during vaccinations
boolean
C0854638 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0042196 (UMLS CUI [2])
Childbearing Potential Pregnancy test negative
Item
women of childbearing age with a negative pregnancy test documented prior to enrollment.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
ECOG performance status
Item
subjects with ecog performance status score of 0 or 1 (appendix d).
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods Willing
Item
subjects willing to use birth control if necessary
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Informed Consent
Item
subjects who have voluntarily signed a written informed consent in accordance with institutional policies after its contents have been fully explained to them.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or lactating females.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity | Hepatitis C positive
Item
subjects with positive hiv or hepatitis c at baseline by report.
boolean
C0019699 (UMLS CUI [1])
C1112419 (UMLS CUI [2])
Blood Coagulation Disorders | Thrombocytopenia | Platelet Count measurement | International Normalized Ratio | Partial thromboplastin time finding
Item
subjects with coagulopathies, including thrombocytopenia with platelet count less than 75,000, inr greater than 1.5 and partial thromboplastin time greater than 50 sec
boolean
C0005779 (UMLS CUI [1])
C0040034 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0525032 (UMLS CUI [4])
C1531697 (UMLS CUI [5])
Heart Disease Major | Cardiac ejection fraction MUGA
Item
subjects with major cardiac illness muga less than 50% ef.
boolean
C0018799 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0232174 (UMLS CUI [2,1])
C0521317 (UMLS CUI [2,2])
Pre-existing condition Interferes with Clinical Trial | Pharmaceutical Preparations Interfere with Clinical Trial
Item
subjects with pre-existing medical illnesses or medications which might interfere with the study as determined by pi.
boolean
C0521987 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial